cannabis policy Related News
Australian Lawyers Alliance: drug policy reform in Australia
Greg Barns, National Criminal Justice Spokesperson for the Australian Lawyers Alliance, calls for evidence-led cannabis policy reform.
One of the most depressing aspects of the...
European Industrial Hemp Association: industrial hemp in Europe
European Industrial Hemp Association Managing Director Lorenza Romanese details the current status of Europe’s hemp industry.
The European Industrial Hemp Association (EIHA), based in both Brussels...
Legislation and regulation in US cannabis
US Cannabis CEO Michael Patterson discusses federal and state cannabis laws and future policy developments.
Michael Patterson is the CEO and founder of US Cannabis...
Regulation and reputation with Medicinal Cannabis Industry Australia
Rosemary Richards of Medicinal Cannabis Industry Australia tells MCN about industry regulation, licensing and the future of Australian cannabis.
Medicinal Cannabis Industry Australia (MCIA), the...
Marijuana Policy Project: state level policy reform, what’s next?
Marijuana Policy Project Communications Manager Violet Cavendish explores the growing push for adult use legalisation in Arizona.
The Marijuana Policy Project (MPP) is the nation’s...
New Zealand’s Medical Cannabis Scheme now launched
New Zealand has now launched its Medical Cannabis Scheme that will help patients gain better access to cannabis medicines.
As of April 1, 2020, New...
The ACI launches new CBD safety certification initiative
The Association for the Cannabinoid Industry (The ACI) today outlined new plans for The ACI CBD Safety Certification programme.
The Association for the Cannabinoid Industry...
Arge Canna: medical cannabis lobbying and patient advocacy in Austria
Mag. Klaus Hübner of patient advocacy body Arge Canna tells MCN about Austria’s medical cannabis legislation and Arge Canna’s campaigns.
Arge Canna is the primary...
The NCIA talks policy, equality and regulation in US cannabis
National Cannabis Industry Association Media Relations Director Morgan Fox tells MCN about regulation, policy reform and representation in the field of US cannabis.
The National...
New poll finds overwhelming public support for FSA CBD regulation
A new YouGov poll commissioned by The Association for the Cannabinoid Industry (The ACI) demonstrates overwhelming support for recent FSA guidance concerning CBD and...
Calls for CBD regulation following inaccurate CBD levels on products
The Digital Citizens Alliance is calling on Congress for CBD regulation as new research has highlighted the inaccuracy of CBD potency levels listed on...
Medical cannabis import restrictions lifted for UK patients
Medical cannabis patients in the UK will now have faster access to their prescriptions thanks to new changes on import restrictions.
The UK government has...
Illicit-vape deaths highlight urgency of legalising cannabis
A report has highlighted how the vape death crisis underscores the importance and urgency of legalising cannabis nationwide.
According to the report Cannabis Vaping: Opportunities...
Three reasons the Conservative government might legalise cannabis
In this article Ian Hamilton of the University of York and Harry Sumnall of Liverpool John Moores University discuss three reasons why the Conservative...
ProPharma: seven things to consider in medical cannabis development
ProPharma Group takes a look at medical cannabis regulation and compliance.
Jan Zorgdrager, PhD, and Marc Stegeman, MSc, Principal Consultants in ProPharma Group’s Life Sciences...
CannaPro: the only solution for CBD is a cannabis regulation authority
Following the issuing of the Food Standards Agency’s (FSA) CBD safety advice, a UK cannabis body, CannaPro, has suggested that the solution for the...
Prohibition Partners Launches the European Cannabis Report: 5th Edition
Leading cannabis market intelligence and strategic consultancy firm Prohibition Partners has launched The European Cannabis Report: 5th Edition.
The report is the latest in Prohibition Partners' suite of...
CBD products do not fall under scope of Novel Food schedule says CTA
The UK Cannabis Trades Association has responded to yesterday’s FSA announcement – stating that CBD does not fall under the scope of the Novel...
Reforming cannabis policy on a state and federal level in the USA
The US-based Marijuana Policy Project aims to ease the burden on patients by campaigning for effective, workable policy reform.
The Marijuana Policy Project (MPP), founded...
The Conservative Drug Policy Reform Group: driving reform in the UK
The Conservative Drug Policy Reform Group weighs in on the current situation surrounding access to cannabis-based medicines in the UK.
The Conservative Drug Policy Reform...
